IDEAYA Biosciences (IDYA) revealed Loss for fourth quarter that missed the Street estimates.
The company's bottom line totaled -$130.3 million, or -$1.49 per share. This compares with -$33.9 million, or -$1.52 per share, last year.
Analysts on average had expected the company to earn -$0.62 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 79.5% to $7 million from $3.9 million last year.
IDEAYA Biosciences earnings at a glance (GAAP) :
-Earnings: -$130.3 Mln. vs. -$33.9 Mln. last year.-EPS: -$1.49 vs. -$1.52 last year.-Revenue: $7 Mln vs. $3.9 Mln last year.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.